70 related articles for article (PubMed ID: 692806)
1. Activity of N-acetyltransferase in patients with malignant lymphomas.
Chekharina YeA ; Bulovskaya LN; Pavlova MV; Krupkin RG
Neoplasma; 1978; 25(4):471-5. PubMed ID: 692806
[TBL] [Abstract][Full Text] [Related]
2. Acetylator phenotyping in patients with malignant lymphomas, using caffeine as the metabolic probe.
William BM; Abdel-tawab AM; Hassan EA; Mohamed OF
Pol J Pharmacol; 2004; 56(4):445-9. PubMed ID: 15520499
[TBL] [Abstract][Full Text] [Related]
3. [Type of acetylation in children with Hodgkin's disease].
Kolygin BA; Bulovskaia LN; Nevolin-Lopatin AM; Safonova SA
Vopr Onkol; 1986; 32(4):52-7. PubMed ID: 3705528
[TBL] [Abstract][Full Text] [Related]
4. [N-acetyltransferase activity during growth of the transplantable Pliss lymphosarcoma and during pregnancy in rats].
Riazanov EM; Aleksandrov VA; Bulovskaia AN
Biull Eksp Biol Med; 1984 Jul; 98(7):68-70. PubMed ID: 6547867
[TBL] [Abstract][Full Text] [Related]
5. [Activity of polymorphic N-acetyltransferase in epilepsy].
Barannikov AS; Trubnikov VI
Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(6):857-61. PubMed ID: 4024808
[TBL] [Abstract][Full Text] [Related]
6. [Acetylation phenotype in patients with cancer of the bladder. Preliminary report].
Skretowicz J; Polakowski P; Jeromin L; Zasada M; Szymańska J; Krajewska B
Med Pr; 1988; 39(4):241-5. PubMed ID: 3237058
[TBL] [Abstract][Full Text] [Related]
7. Metabolic activation of N-hydroxy-2-aminofluorene and N-hydroxy-2-acetylaminofluorene by monomorphic N-acetyltransferase (NAT1) and polymorphic N-acetyltransferase (NAT2) in colon cytosols of Syrian hamsters congenic at the NAT2 locus.
Hein DW; Doll MA; Gray K; Rustan TD; Ferguson RJ
Cancer Res; 1993 Feb; 53(3):509-14. PubMed ID: 8425184
[TBL] [Abstract][Full Text] [Related]
8. Acetylation pharmacogenetics. The slow acetylator phenotype is caused by decreased or absent arylamine N-acetyltransferase in human liver.
Grant DM; Mörike K; Eichelbaum M; Meyer UA
J Clin Invest; 1990 Mar; 85(3):968-72. PubMed ID: 2312737
[TBL] [Abstract][Full Text] [Related]
9. [Phenotypic changes in acetylation in tumor patients].
Bulovskaia LN; Blinov NN; Simonov NN; Krupkin RG; Kolosov AI
Vopr Onkol; 1978; 24(10):76-9. PubMed ID: 716322
[TBL] [Abstract][Full Text] [Related]
10. [Determination of the N-acetyltransferase phenotype in urothelial cancer patients and healthy controls].
Sone M
Hinyokika Kiyo; 1986 Aug; 32(8):1085-92. PubMed ID: 3788733
[TBL] [Abstract][Full Text] [Related]
11. Relationship between in vivo acetylator phenotypes and cytosolic N-acetyltransferase and O-acetyltransferase activities in human uroepithelial cells.
Frederickson SM; Messing EM; Reznikoff CA; Swaminathan S
Cancer Epidemiol Biomarkers Prev; 1994; 3(1):25-32. PubMed ID: 8118381
[TBL] [Abstract][Full Text] [Related]
12. Identification and kinetic characterization of acetylator genotype-dependent and -independent arylamine carcinogen N-acetyltransferases in hamster bladder cytosol.
Yerokun T; Kirlin WG; Trinidad A; Ferguson RJ; Ogolla F; Andrews AF; Brady PK; Hein DW
Drug Metab Dispos; 1989; 17(3):231-7. PubMed ID: 2568902
[TBL] [Abstract][Full Text] [Related]
13. Sulfadimidine acetylation in Norwegians. Comparison of sulfadimidine metabolism in Lapps, North Norwegians and South Norwegians.
Olsen H; Mørland J
Acta Med Scand; 1981; 210(1-2):119-24. PubMed ID: 7293820
[TBL] [Abstract][Full Text] [Related]
14. [Acetylation processes in chronic alcoholics].
Kovalev IE; Kovalev EN; Seleznev NG
Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(2):232-4. PubMed ID: 6711211
[TBL] [Abstract][Full Text] [Related]
15. N-acetyltransferase 2 phenotype but not NAT1*10 genotype affects aminobiphenyl-hemoglobin adduct levels.
Probst-Hensch NM; Bell DA; Watson MA; Skipper PL; Tannenbaum SR; Chan KK; Ross RK; Yu MC
Cancer Epidemiol Biomarkers Prev; 2000 Jun; 9(6):619-23. PubMed ID: 10868698
[TBL] [Abstract][Full Text] [Related]
16. Interdependence of O2 consumption, renal NEFA pattern and N-acetylation of PAH in the isolated perfused rat kidney. Effect of long-chain NEFA and of PGF2 alpha on the renal N-acetyltransferase activity.
Mályusz M; Ehrens J; Uschtrin D
Ren Physiol; 1982; 5(4):165-72. PubMed ID: 7122980
[TBL] [Abstract][Full Text] [Related]
17. Cigarette smoking, N-acetyltransferase 2 acetylation status, and bladder cancer risk: a case-series meta-analysis of a gene-environment interaction.
Marcus PM; Hayes RB; Vineis P; Garcia-Closas M; Caporaso NE; Autrup H; Branch RA; Brockmöller J; Ishizaki T; Karakaya AE; Ladero JM; Mommsen S; Okkels H; Romkes M; Roots I; Rothman N
Cancer Epidemiol Biomarkers Prev; 2000 May; 9(5):461-7. PubMed ID: 10815690
[TBL] [Abstract][Full Text] [Related]
18. [Acetylation phenotype in patients with periodic disease].
Podymov VK; Vinogradova OM; Kovaleva VL; Kochubeĭ LN; Galstian SM
Ter Arkh; 1988; 60(6):95-8. PubMed ID: 3206381
[TBL] [Abstract][Full Text] [Related]
19. Genetic control of acetyl coenzyme A-dependent arylamine N-acetyltransferase, hydrazine N-acetyltransferase, and N-hydroxy-arylamine O-acetyltransferase enzymes in C57BL/6J, A/J, AC57F1, and the rapid and slow acetylator A.B6 and B6.A congenic inbred mouse.
Hein DW; Trinidad A; Yerokun T; Ferguson RJ; Kirlin WG; Weber WW
Drug Metab Dispos; 1988; 16(3):341-7. PubMed ID: 2900723
[TBL] [Abstract][Full Text] [Related]
20. In vitro analysis of histone acetyltransferase activity.
Benson LJ; Annunziato AT
Methods; 2004 May; 33(1):45-52. PubMed ID: 15039086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
